Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Alfresa Holdings ( (JP:2784) ) is now available.
Alfresa Holdings Corporation has announced a transition to a company with an audit and supervisory committee structure to enhance its corporate governance. This change aims to improve management decision-making and corporate value by separating business supervision from execution and strengthening the Board of Directors’ monitoring functions.
More about Alfresa Holdings
The Alfresa Group is a leader in the Japanese healthcare industry, focusing on ethical pharmaceuticals wholesaling, OTC pharmaceuticals wholesaling, pharmaceutical manufacturing, and operating dispensing pharmacies. The company aims to fulfill its corporate philosophy of creating and delivering a fresh life for all.
YTD Price Performance: -3.61%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.66B
For an in-depth examination of 2784 stock, go to TipRanks’ Stock Analysis page.